Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Novartis day

Senators attack Novartis over ‘unconscionable’ handling of Zolgensma data

Ask FDA to hold the company ‘accountable’

How is the NHS Long-term Plan being put into action?

Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published

Wilmington Healthcare

- PMLiVE

Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing

OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.

OPEN Health

- PMLiVE

AI’s role in pharma marketing

by David Laros

Lucid Group supercharges its client services team with four spellbinding new hires

Lucid Group makes four magical additions to its client services team!Annabel Lloyd joins Vivid as an account director. With experience in a variety of therapy areas from immunology, oncology, CVD...

Lucid Group Communications Limited

- PMLiVE

The evolution of real-world studies

How industry and regulators are using real-world data

- PMLiVE

Real-world studies

by Bill Row

- PMLiVE

Sarepta investigating mistakenly submitted Duchenne therapy report

Study participant fell seriously ill

- PMLiVE

Additional investment ‘desperately needed’ as NHS performance figures show record highs

A&E attendances at record numbers

- PMLiVE

Tagrisso tops rival drugs on survival in first-line lung cancer

Takes fight to Pfizer's Vizimpro

Bayer symbol

Bayer takes control of BlueRock stem cell joint venture

Deal values BlueRock at $1bn

- PMLiVE

ICER closely monitoring FDA’s Zolgensma investigation

Could affect initial cost assessment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links